The Significance of Blood-tryptase and c-Kit Mutation in Insect Venom Immunotherapy
The Significance of Blood-tryptase Levels and c-Kit Mutation in the Evaluation of Prognosis and Adverse Reactions in Subjects Undergoing Venom Immunotherapy for Insect Allergy
Sponsor: Meir Medical Center
This observational or N/A phase trial investigates Hypersensitivity, Immediate and Insect Bites and Stings and is currently completed. Meir Medical Center leads this study, which shows 11 recorded versions since 2015 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
11 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Dec 2021 — Jul 2024 [monthly]
Completed
-
Jan 2021 — Dec 2021 [monthly]
Completed
-
Nov 2020 — Jan 2021 [monthly]
Completed
▶ Show 6 earlier versions
-
Sep 2019 — Nov 2020 [monthly]
Completed
Status: Recruiting → Completed
-
Jun 2018 — Sep 2019 [monthly]
Recruiting
-
May 2018 — Jun 2018 [monthly]
Recruiting
-
Apr 2018 — May 2018 [monthly]
Recruiting
Status: Unknown Status → Recruiting · Phase: NA → None
-
Aug 2017 — Apr 2018 [monthly]
Unknown Status NA
Status: Not Yet Recruiting → Unknown Status
-
Jan 2017 — Aug 2017 [monthly]
Not Yet Recruiting NA
First recorded
Aug 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Meir Medical Center
For direct contact, visit the study record on ClinicalTrials.gov .